Last Updated: June 22, 2026

LOTEPREDNOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for LOTEPREDNOL?
  • What are the global sales for LOTEPREDNOL?
  • What is Average Wholesale Price for LOTEPREDNOL?
Summary for LOTEPREDNOL
US Patents:0
Applicants:7
NDAs:14
Drug Prices: Drug price information for LOTEPREDNOL
DailyMed Link:LOTEPREDNOL at DailyMed

US Patents and Regulatory Information for LOTEPREDNOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma LOTEPREDNOL ETABONATE loteprednol etabonate GEL;OPHTHALMIC 213956-001 Nov 29, 2023 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lupin LOTEPREDNOL ETABONATE loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 215550-001 Dec 26, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm LOTEPREDNOL ETABONATE loteprednol etabonate GEL;OPHTHALMIC 215384-001 Aug 9, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sentiss LOTEPREDNOL ETABONATE loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 207609-001 Apr 17, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lupin LOTEPREDNOL ETABONATE loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 215719-001 Apr 24, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Alembic LOTEPREDNOL ETABONATE AND TOBRAMYCIN loteprednol etabonate; tobramycin SUSPENSION/DROPS;OPHTHALMIC 217597-001 Dec 10, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lupin LOTEPREDNOL ETABONATE loteprednol etabonate GEL;OPHTHALMIC 218087-001 Jun 30, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.